ENAPOTAMAB VEDOTIN
UNII 43HH4XYH2N

Substance Identification & Data

This profile provides standardized clinical and technical data for Enapotamab Vedotin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 43HH4XYH2N.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1912424-97-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

43HH4XYH2N

CAS Registry Number

1912424-97-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ENAPOTAMAB VEDOTIN

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C132017

National Cancer Institute reference terminology for clinical and research data.

INN ID

10769

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Enapotamab Vedotin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ENAPOTAMAB VEDOTIN

Common Names & Synonyms

AXL-107-MMAE

ENAPOTAMAB VEDOTIN [INN]

ENAPOTAMAB VEDOTIN [WHO-DD]

IMMUNOGLOBULIN G1, ANTI-(HUMAN GROWTH FACTOR RECEPTOR AXL)(HUMAN HUMAX-AXL .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN HUMAX-AXL .KAPPA.-CHAIN, DIMER TETRAKIS(THIOETHER) WITH VEDOTIN

IMMUNOGLOBULIN G1, ANTI-(HUMAN GROWTH FACTOR RECEPTOR AXL)(HUMAN HUMAX-AXL GAMMA LIGHT CHAIN), DISULFIDE WITH HUMAN HUMAX-AXL KAPPA CHAIN, DIMER, MONOMETHYL AURISTATIN E CONJUGATE

Technical Codes

HUMAXAXLADC

HUMAX-AXL-ADC

External Clinical & Regulatory Resources

Previous UNII43H6SBP55W

Next UNII43HMV2KS5O